Fournier's gangrene (FG) is a rare progressive necrotizing fasciitis (NF) with high mortality rate. This case report describes a young patient with FG with no known history of disease or invasive therapeutic interventions.
Background and Aim: Anal surgery is relatively common, and rarely is performed as an outpatient opration procedure due to concerns about postoperative pain. The present study aimed to compare the effects of rectal acetaminophen and diclofenac suppositories on pain control after anal surgery (hemorrhoidectomy) in adult patients. Materials and Methods: This clinical trial study was conducted in Zahedan in 2013 and included 70 patients who underwent hemorrhoidectomy. The patients were divided into two groups, one group received rectal acetaminophen and the other one used diclofenac suppositories. Pain intensity was measured by visual analogve score system at different time intervals (0, 2, 4, 12, and 24 hours). Data were analyzed by relevant statistical test. Results: Pain intensity at different times in the study was significantly lower in the diclofenac suppository group compared to that in the acetaminophen suppository group. The mean time intervals needed for drug administration in the diclofenac group was 183.14 ± 26.98 minutes and 166.85 ± 27.30 minutes in the acetaminophen group; therefore, a statistically significant difference was observed between the two groups. Conclusion: Diclofenac suppository showed a better analgesic effect than acetaminophen suppository in post-hemorrhoidectomy pain management. Use of diclofenac suppositories can have more satisfactory results in reducing postoperative pain.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.